ARTICLE | Company News
Acorda, Alkermes, Biogen Idec autoimmune news
January 6, 2014 8:00 AM UTC
On Dec. 19, 2013, Acorda said the European Patent Office's opposition division upheld claims in European Patent EP-1 732,548 B, covering Acorda's sustained-release formulation of 4-aminopyridine (4-AP...